Themis Medicare

Themis Medicare Limited operates within the pharmaceuticals business segment, specializing in the manufacturing of pharmaceutical products, including formulations and Active Pharmaceutical Ingredients (API). Looking ahead, the company is optimistic about the growth prospects for both the domestic and global pharmaceutical industry. This move aligns with the company's commitment to enhancing operational efficiency and optimizing working capital management. In its formulations business, the focus on hospital and trade business has yielded positive results with a notable increase in branded business in the domestic market. Furthermore, the company is committed to innovation in its intensive care portfolio, where it aims to expand product offerings to meet evolving market demands. The company markets its products in over 44 countries and has a nationwide network of more than 4000 stockists.;